340B Health said Thursday that Eli Lilly has cut off 340B pricing for certain hospitals that did not comply with its in-house pharmacy claims data reporting requirements.
Two hospital trade groups today confirmed that pharmaceutical giant Eli Lilly cut off 340B pricing for certain hospitals that did [...]
Please Login or Become a Paid Subscriber to View this Content